Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ALPMF

Recent news which mentions ALPMF

Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
Tickers ALPMF ALPMY NEWS PFE
Tags Briefs PFE Stories That Matter
From Benzinga
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Tickers ALPMF ALPMY ELEV
Tags ELEV Benzinga ALPMF
From Benzinga
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Tickers ALPMF ALPMY NEWS PFE
Tags why it's moving Contracts RHHBY
From Benzinga
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags General Price Target Briefs
From Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
Tickers ALPMF ALPMY AZN MRK
Tags Briefs PFE Stories That Matter
From Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Tickers ALPMF BAYRY BAYZF DARE
Tags General Stories That Matter BAYZF
From Benzinga
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
Tickers ALPMF ALPMY MRK SGEN
Tags Biotech ALPMY ALPMF
From Benzinga
Why Is Seagen Stock Trading Higher Today?
Tickers ALPMF ALPMY MRK SGEN
Tags Briefs News Movers
From Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
Tickers ALPMF ALPMY TSHA
Tags ALPMF Movers Biotech
From Benzinga
Why Shares of Adaptive Biotechnologies Jumped This Week
Tickers ADPT ALPMF
Tags Recent Press Releases ALPMF Market News
From Motley Fool
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
Tickers ALPMF ALPMY
Tags General Market News Briefs
From Benzinga
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
Tickers ALPMF ISEE OKYO VTRS
Tags OKYO Pharma ALPMF Benzinga
From Benzinga
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
Tickers AAPL ALPMF ALPMY BTI
Tags News SPY Health Care
From Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
Tickers ALPMF ALPMY
Tags Market News General FDA
From Benzinga
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Tickers ALPMF ALPMY PFE
Tags General Market News PFE
From Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
Tickers ALPMF ALPMY ISEE
Tags Benzinga Health Care ALPMF
From Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
Tickers ALPMF ALPMY MRK SGEN
Tags Briefs Large Cap News
From Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
Tickers ABBV ALPMF BMY CTMX
Tags Contracts why it's moving BMY
From Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
Tickers ALPMF ALPMY
Tags News Health Care ALPMY
From Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Tickers ALPMF ALPMY PFE
Tags General Market News PFE
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags ALPMY SELB Reiteration
From Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags NVS M&A Market News
From Benzinga
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
Tickers ALPMF ALPMY TSHA
Tags Market News M&A why it's moving
From Benzinga
Astellas' Menopause Drug Under FDA Review
Tickers ALPMF ALPMY
Tags Biotech ALPMY ALPMF
From Benzinga
Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say
Tickers ALPMF SGEN
Tags Health Care Trading Ideas Analyst Color
From Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Tickers ABBV ALPMF ANGN BIIB
Tags Financing LEGN IONS
From Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
Tickers ALPMF ALPMY MRK SGEN
Tags Benzinga Movers Biotech
From Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
Tickers ALPMF CNTG ELYM EPIX
Tags SPRO KZR Contracts
From Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Tickers ALPMF ALPMY STRO
Tags General Benzinga ALPMF
From Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags Trading Ideas AXSM GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.